Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025713
Filing Date
2020-09-18
Accepted
2020-09-18 16:17:45
Documents
2
Period of Report
2020-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4230
2 EX-24 DOCUMENT attachment1.htm EX-24 4429
  Complete submission text file 0000899243-20-025713.txt   10222
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Reporting) CIK: 0001055919 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 201184194

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations